Disclosure of information on specialized contract manufacturing companies for biopharmaceuticals

News Healthcare & Pharma General Updates

Date: 29th Nov, 2024 Source: Korea Food and Drug Administration (KFDA) Country: South Korea Original Source

Brief

"On 29/11/2024, the Korea Food and Drug Administration (KFDA) issued an update regarding Disclosure of information on specialized contract manufacturing companies for biopharmaceuticals. The KFDA will disclose information on 19 domestic biopharmaceutical specialized contract manufacturers, including their company details and Good Manufacturing Practice (GMP) certificates, to facilitate industry growth."

This content is restricted.

Highlights content goes here...

This content is restricted.

Korea Food and Drug Administration (KFDA)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Disclosure of information on specialized contract manufacturing companies for biopharmaceuticals

Brief

Korea Food and Drug Administration (KFDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Disclosure of information on specialized contract manufacturing companies for biopharmaceuticals

Brief

Korea Food and Drug Administration (KFDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.